129 related articles for article (PubMed ID: 29313073)
1. Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
Yuan X; Yang M; Chen X; Zhang X; Sukhadia S; Musolino N; Bao H; Chen T; Xu C; Wang Q; Santoro S; Ricklin D; Hu J; Lin R; Yang W; Li Z; Qin W; Zhao A; Scholler N; Coukos G
Cancer Immunol Immunother; 2018 Feb; 67(2):329-339. PubMed ID: 29313073
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
Yuan X; Yang M; Chen X; Zhang X; Sukhadia S; Musolino N; Bao H; Chen T; Xu C; Wang Q; Santoro S; Ricklin D; Hu J; Lin R; Yang W; Li Z; Qin W; Zhao A
Cancer Immunol Immunother; 2017 Mar; 66(3):367-378. PubMed ID: 27933426
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):979-991. PubMed ID: 31993928
[TBL] [Abstract][Full Text] [Related]
4. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
Guo Y; Hu J; Wang Y; Peng X; Min J; Wang J; Matthaiou E; Cheng Y; Sun K; Tong X; Fan Y; Zhang PJ; Kandalaft LE; Irving M; Coukos G; Li C
Eur J Cancer; 2018 Feb; 90():111-121. PubMed ID: 29304474
[TBL] [Abstract][Full Text] [Related]
5. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.
Zhao A; Nunez-Cruz S; Li C; Coukos G; Siegel DL; Scholler N
J Immunol Methods; 2011 Jan; 363(2):221-32. PubMed ID: 20837020
[TBL] [Abstract][Full Text] [Related]
6. Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer.
Li C; Wang J; Hu J; Feng Y; Hasegawa K; Peng X; Duan X; Zhao A; Mikitsh JL; Muzykantov VR; Chacko AM; Pryma DA; Dunn SM; Coukos G
Oncotarget; 2014 Aug; 5(16):6994-7012. PubMed ID: 25051365
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy.
Marty C; Langer-Machova Z; Sigrist S; Schott H; Schwendener RA; Ballmer-Hofer K
Cancer Lett; 2006 Apr; 235(2):298-308. PubMed ID: 15953677
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.
Li C; Chacko AM; Hu J; Hasegawa K; Swails J; Grasso L; El-Deiry WS; Nicolaides N; Muzykantov VR; Divgi CR; Coukos G
Cancer Biol Ther; 2014 Apr; 15(4):443-51. PubMed ID: 24553243
[TBL] [Abstract][Full Text] [Related]
9. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1.
Fierle JK; Brioschi M; de Tiani M; Wetterwald L; Atsaves V; Abram-Saliba J; Petrova TV; Coukos G; Dunn SM
Cell Rep Med; 2021 Aug; 2(8):100362. PubMed ID: 34467246
[TBL] [Abstract][Full Text] [Related]
10. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
Piazza T; Cha E; Bongarzone I; Canevari S; Bolognesi A; Polito L; Bargellesi A; Sassi F; Ferrini S; Fabbi M
J Cell Sci; 2005 Apr; 118(Pt 7):1515-25. PubMed ID: 15769845
[TBL] [Abstract][Full Text] [Related]
11. Correction to: Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):992. PubMed ID: 32198704
[TBL] [Abstract][Full Text] [Related]
12. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
[TBL] [Abstract][Full Text] [Related]
13. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
15. Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter.
Huang HP; Hong CL; Kao CY; Lin SW; Lin SR; Wu HL; Shi GY; You LR; Wu CL; Yu IS
Gene Expr Patterns; 2011; 11(5-6):316-26. PubMed ID: 21402174
[TBL] [Abstract][Full Text] [Related]
16. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
17. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
19. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
20. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
